[
  {
    "title": "UPDATE 1-Regeneron to defend against DOJ complaint on drug-price manipulation",
    "published": 1713225553,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Regeneron to defend against DOJ complaint on drug-price manipulation",
    "published": 1713223442,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Regeneron to defend US Justice Department's complaint on drug-pricing manipulation",
    "published": 1713223204,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Regeneron Pharmaceuticals : Statement on Department of Justice Filing Related to EYLEA\u00ae (aflibercept) Injection 2 mg",
    "published": 1713208027,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Regeneron commits $500M to new venture capital fund",
    "published": 1713181500,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Antitrust fervor is gripping Washington and Silicon Valley. But lawsuits have been declining.",
    "published": 1713106815,
    "posting_price": 914.19522318,
    "close_price": 897.40679932,
    "percent_change": -1.83641562
  },
  {
    "title": "Regeneron (REGN) Accused of Fraudulent Practices Related to Eylea",
    "published": 1712944440,
    "posting_price": 910.38012491,
    "close_price": 903.53894043,
    "percent_change": -0.75146461
  },
  {
    "title": "Breaking Down Regeneron Pharmaceuticals: 13 Analysts Share Their Views",
    "published": 1712912640,
    "posting_price": 910.38012491,
    "close_price": 903.53894043,
    "percent_change": -0.75146461
  },
  {
    "title": "Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)",
    "published": 1712907240,
    "posting_price": 910.38012491,
    "close_price": 903.53894043,
    "percent_change": -0.75146461
  },
  {
    "title": "Regeneron price target raised by $10 at BofA, here's why",
    "published": 1712901600,
    "posting_price": 910.38012491,
    "close_price": 903.53894043,
    "percent_change": -0.75146461
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)",
    "published": 1712895660,
    "posting_price": 910.38012491,
    "close_price": 903.53894043,
    "percent_change": -0.75146461
  },
  {
    "title": "Stocks to Watch Thursday: Robinhood, Alpine Immune, Constellation Brands",
    "published": 1712843913,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "Are Regeneron's Legal Troubles \u2014 And Six-Week Slide \u2014 A Buying Opportunity?",
    "published": 1712854911,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "Dow Jones Lower Despite PPI Inflation Relief; Nvidia, Microsoft Price Targets Raised",
    "published": 1712845662,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "Regeneron hits three-month low after DOJ complaint; RBC defends",
    "published": 1712837940,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking",
    "published": 1712834340,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "US sues Regeneron, alleging false price reporting on Eylea",
    "published": 1712833560,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "RBC sees buying opportunity following Regeneron's 'overdone DOJ downside'",
    "published": 1712833140,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "These Stocks Are Moving the Most Today: Alpine Immune, Vertex, Robinhood, Regeneron, Costco, Constellation Brands, CarMax, and More",
    "published": 1712830200,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "DOJ files complaint against Regeneron over Eylea Medicare pricing",
    "published": 1712822340,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "Regeneron (NASDAQ:REGN) Accused of Manipulating Pricing of Eylea",
    "published": 1712817060,
    "posting_price": 927.38826373,
    "close_price": 919.13885498,
    "percent_change": -0.88953129
  },
  {
    "title": "US accuses Regeneron of fraudulent price reporting for eye drug",
    "published": 1712782751,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "UPDATE 2-US accuses Regeneron of fraudulent price reporting for eye drug",
    "published": 1712782369,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "US Justice department files complaint against Regeneron, alleges fraudulent drug pricing",
    "published": 1712768351,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "An Intrinsic Calculation For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Suggests It's 47% Undervalued",
    "published": 1712754010,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "Regeneron accused of \u2018fraudulent\u2019 drug-pricing reporting for eye drug Eylea",
    "published": 1712741700,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "DOJ sues Regeneron over Eylea Medicare pricing",
    "published": 1712722320,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "DOJ files false claims act complaint against Regeneron over drug pricing",
    "published": 1712719620,
    "posting_price": 933.81999587,
    "close_price": 934.99847412,
    "percent_change": 0.12619972
  },
  {
    "title": "EXEL or REGN: Which Is the Better Value Stock Right Now?",
    "published": 1712677212,
    "posting_price": 940.18185834,
    "close_price": 942.6786499,
    "percent_change": 0.26556475
  },
  {
    "title": "Video: S&P 500 Analyst Moves: REGN",
    "published": 1712661960,
    "posting_price": 940.18185834,
    "close_price": 942.6786499,
    "percent_change": 0.26556475
  },
  {
    "title": "Regeneron Pharmaceuticals Achieves #96 Analyst Rank, Surpassing Costco Wholesale",
    "published": 1712661900,
    "posting_price": 940.18185834,
    "close_price": 942.6786499,
    "percent_change": 0.26556475
  },
  {
    "title": "Regeneron (REGN) Receives a Buy from RBC Capital",
    "published": 1712641560,
    "posting_price": 940.18185834,
    "close_price": 942.6786499,
    "percent_change": 0.26556475
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Veeva Systems (VEEV) and Ultragenyx Pharmaceutical (RARE)",
    "published": 1712638200,
    "posting_price": 940.18185834,
    "close_price": 942.6786499,
    "percent_change": 0.26556475
  },
  {
    "title": "Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma",
    "published": 1712520000,
    "posting_price": 937.95463265,
    "close_price": 937.2755127,
    "percent_change": -0.07240435
  },
  {
    "title": "Regeneron presents pivotal data from Phase 1/2 LINKER-MM1 trial of linvoseltamab",
    "published": 1712461800,
    "posting_price": 937.95463265,
    "close_price": 937.2755127,
    "percent_change": -0.07240435
  },
  {
    "title": "Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen impressive returns of 146% over the past five years",
    "published": 1712404890,
    "posting_price": 937.95463265,
    "close_price": 937.2755127,
    "percent_change": -0.07240435
  },
  {
    "title": "Should You Sell This Stock Following a Regulatory Roadblock?",
    "published": 1712314800,
    "posting_price": 938.10450936,
    "close_price": 941.49017334,
    "percent_change": 0.36090478
  },
  {
    "title": "Regeneron Pharmaceuticals Inc. stock rises Friday, still underperforms market",
    "published": 1712288700,
    "posting_price": 938.10450936,
    "close_price": 941.49017334,
    "percent_change": 0.36090478
  },
  {
    "title": "Kodiak (KOD) Counts on Tarcocimab Program Despite Setbacks",
    "published": 1712246940,
    "posting_price": 960.96512041,
    "close_price": 935.81744385,
    "percent_change": -2.61691876
  },
  {
    "title": "LLY, REGN, BHVN: Which Biotech Stock Offers the Most Upside?",
    "published": 1712196187,
    "posting_price": 960.96512041,
    "close_price": 935.81744385,
    "percent_change": -2.61691876
  },
  {
    "title": "Biotech Roundtable: Who will bring the next CRISPR drug to market?",
    "published": 1712054340,
    "posting_price": 960.20610704,
    "close_price": 953.45477295,
    "percent_change": -0.70311301
  },
  {
    "title": "Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?",
    "published": 1714481220,
    "posting_price": 890.96505801,
    "close_price": 889.51690674,
    "percent_change": -0.16253738
  },
  {
    "title": "Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends",
    "published": 1714469580,
    "posting_price": 890.96505801,
    "close_price": 889.51690674,
    "percent_change": -0.16253738
  },
  {
    "title": "Down -8.24% in 4 Weeks, Here's Why Regeneron (REGN) Looks Ripe for a Turnaround",
    "published": 1714397705,
    "posting_price": 882.06653614,
    "close_price": 891.33459473,
    "percent_change": 1.05072103
  },
  {
    "title": "Countdown to Regeneron (REGN) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS",
    "published": 1714396560,
    "posting_price": 882.06653614,
    "close_price": 891.33459473,
    "percent_change": 1.05072103
  },
  {
    "title": "EYLEA\u00ae HD (aflibercept) Injection 8 mg Presentations at ARVO Reinforce Sustained and Clinically Meaningful Outcomes in Serious Retinal Diseases",
    "published": 1714388400,
    "posting_price": 882.06653614,
    "close_price": 891.33459473,
    "percent_change": 1.05072103
  },
  {
    "title": "Regeneron announces presentations on EYLEA HD, EYLEA Injection at ARVO meeting",
    "published": 1714371420,
    "posting_price": 882.06653614,
    "close_price": 891.33459473,
    "percent_change": 1.05072103
  },
  {
    "title": "Interesting REGN Put And Call Options For June 7th",
    "published": 1714132380,
    "posting_price": 880.58838628,
    "close_price": 882.06652832,
    "percent_change": 0.16785845
  },
  {
    "title": "Regeneron price target raised by $50 at Oppenheimer, here's why",
    "published": 1714117320,
    "posting_price": 880.58838628,
    "close_price": 882.06652832,
    "percent_change": 0.16785845
  },
  {
    "title": "DOJ Files False Claims Act Complaint Against Regeneron, Alleging Fraudulent Eylea Drug Pricing",
    "published": 1714104730,
    "posting_price": 880.58838628,
    "close_price": 882.06652832,
    "percent_change": 0.16785845
  },
  {
    "title": "Barclays Sticks to Their Buy Rating for Regeneron (REGN)",
    "published": 1714103340,
    "posting_price": 880.58838628,
    "close_price": 882.06652832,
    "percent_change": 0.16785845
  },
  {
    "title": "EXEL vs. REGN: Which Stock Is the Better Value Option?",
    "published": 1714059612,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron (REGN) Reports Next Week: What You Should Expect",
    "published": 1714053733,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study",
    "published": 1714049044,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases",
    "published": 1714042800,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth",
    "published": 1714042800,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "AbbVie reports positive results from Rinvoq versus Dupixent study",
    "published": 1714041000,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron Sets Crispr-Based Collaboration With Mammoth Biosciences",
    "published": 1714032327,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies",
    "published": 1714029900,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron expands in gene editing with Mammoth deal",
    "published": 1714028400,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron, Mammoth collaborate to purse next-generation gene editing",
    "published": 1714026540,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Wells Fargo Reaffirms Their Buy Rating on Regeneron (REGN)",
    "published": 1714020300,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study",
    "published": 1714006920,
    "posting_price": 909.92070452,
    "close_price": 889.53686523,
    "percent_change": -2.24017754
  },
  {
    "title": "Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO",
    "published": 1713967500,
    "posting_price": 905.73611018,
    "close_price": 905.37652588,
    "percent_change": -0.03970078
  },
  {
    "title": "Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape",
    "published": 1713965674,
    "posting_price": 905.73611018,
    "close_price": 905.37652588,
    "percent_change": -0.03970078
  },
  {
    "title": "Regeneron price target raised by $10 at TD Cowen, here's why",
    "published": 1713939660,
    "posting_price": 905.73611018,
    "close_price": 905.37652588,
    "percent_change": -0.03970078
  },
  {
    "title": "Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)",
    "published": 1713822840,
    "posting_price": 903.37908325,
    "close_price": 899.00469971,
    "percent_change": -0.48422458
  },
  {
    "title": "Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?",
    "published": 1713773820,
    "posting_price": 903.37908325,
    "close_price": 899.00469971,
    "percent_change": -0.48422458
  },
  {
    "title": "MDL Panel Grants Transfer Of Aflibercept BPCIA Case",
    "published": 1713773408,
    "posting_price": 903.37908325,
    "close_price": 899.00469971,
    "percent_change": -0.48422458
  },
  {
    "title": "Regeneron (REGN) Gets a Buy from Piper Sandler",
    "published": 1713771060,
    "posting_price": 903.37908325,
    "close_price": 899.00469971,
    "percent_change": -0.48422458
  },
  {
    "title": "Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution",
    "published": 1713535217,
    "posting_price": 912.79695904,
    "close_price": 895.66900635,
    "percent_change": -1.87642526
  },
  {
    "title": "Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success",
    "published": 1713462900,
    "posting_price": 900.10334062,
    "close_price": 892.84265137,
    "percent_change": -0.80665063
  },
  {
    "title": "The Law Offices of Frank R. Cruz Announces Investigation of Regeneron Pharmaceuticals, Inc. (REGN) on Behalf of Investors",
    "published": 1713363366,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "If You Invested $100 In This Stock 20 Years Ago, You Would Have $6,700 Today",
    "published": 1713355380,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "Wall Street Analysts Are Bullish on Top Healthcare Picks",
    "published": 1713340860,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "Cantor Fitzgerald Reaffirms Their Hold Rating on Regeneron (REGN)",
    "published": 1713333360,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "published": 1713325680,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick",
    "published": 1713318060,
    "posting_price": 902.71993624,
    "close_price": 900.03338623,
    "percent_change": -0.29760615
  },
  {
    "title": "Why Regeneron (REGN) Could Beat Earnings Estimates Again",
    "published": 1713283815,
    "posting_price": 896.06849597,
    "close_price": 892.99249268,
    "percent_change": -0.3432777
  },
  {
    "title": "Regeneron to 'vigorously defend' against DOJ on Eylea pricing complaint",
    "published": 1713253500,
    "posting_price": 896.06849597,
    "close_price": 892.99249268,
    "percent_change": -0.3432777
  },
  {
    "title": "Regeneron to \u201cvigorously defend\u201d against DOJ on Eylea pricing complaint",
    "published": 1713253140,
    "posting_price": 896.06849597,
    "close_price": 892.99249268,
    "percent_change": -0.3432777
  }
]